Comparing Carbidopa / Levodopa vs Foscarbidopa / Foslevodopa
| Carbidopa / levodopa | Foscarbidopa / foslevodopa |
|
|---|
| Carbidopa / levodopa | Foscarbidopa / foslevodopa |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Carbidopa/levodopa is a medication that may be used for the treatment of Parkinson's disease. Available as immediate-release tablets, extended-release tablets, and extended-release capsules... View more |
Prescription only
Prescribed for Parkinson's Disease. Foscarbidopa / foslevodopa may also be used for purposes not listed in this medication guide. |
Related suggestions Popular comparisons
|
|||||||
| More about Carbidopa / levodopa | More about Foscarbidopa / foslevodopa | ||||||||
| Ratings & Reviews | |||||||||
|
Carbidopa / levodopa has an average rating of 7.1 out of 10 from a total of 105 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 18% reported a negative effect. |
Foscarbidopa / foslevodopa has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Carbidopa / levodopa side effects |
|||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Carbidopa / levodopa prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Atamet, Crexont, Dhivy, Duopa, Parcopa, Rytary, Sinemet | Vyalev | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
2.3 hours |
N/A |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 523 drugs are known to interact with Carbidopa / levodopa:
|
A total of 499 drugs are known to interact with Foscarbidopa / foslevodopa:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
May 02, 1975 |
October 16, 2024 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.